|
|
News Breaks | | | | October 9, 2012 | | 12:35 EDT |  | DGX, MMM | Quest Diagnostics unit, 3M say FDA gives clearance for Simplexa test
Focus Diagnostics, a business of Quest Diagnostics (DGX), and 3M (MMM) announced that the U.S. Food and Drug Administration has provided 510(k) clearance and CLIA moderate-complexity categorization to the Simplexa Flu A/B & RSV Direct test on the 3M Integrated Cycler. The new test aids in the qualitative detection and differentiation of RNA of influenza A and B viruses and respiratory syncytial virus, common causes of respiratory illness. The Simplexa Flu A/B & RSV Direct is now available in the United States. It was CE marked for distribution in Europe in 2011. | |
|
News For DGX;MMM From The Last 14 Days Check below for free stories on DGX;MMM the last two weeks. |
|
|
| May 24, 2013 | | 16:37 EDT | | DGX | Vermillion sends notice of default to Quest Diagnostics
 Subscribe for More Information | | | May 20, 2013 | | 07:32 EDT |  | MMM | Society for Information Display / IHS to host a conference
Display Week 2013 is being held in Vancouver, British Columbia on May 19-24. | | | May 16, 2013 | | 10:10 EDT | | DGX | Quest Diagnostics Humana acquires Concentra's laboratory business
Subscribe for More Information | | | May 15, 2013 | | 17:30 EDT | | DGX | Relational Investors gives quarterly update on stakes
Subscribe for More Information | |
|
|
|
|
|
|
